Who invested in Datacurve?
Datacurve's investors include Mark Goldberg at Chemistry, Y Combinator, Pioneer Fund, Afore Capital and Balaji Srinivasan, and 4 more on record. Mark Goldberg at Chemistry led its latest round.
Who invested in Datacurve
One round we have observed, with the 9 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Datacurve and see its new rounds in your feed. Start following
Funding summaryUpdated 5 Nov 2026
$15Mraised across 1 round since 2025, from 1 source
- Latest round
- Series A, $15MOct 2025
- Led by
- Mark Goldberg at Chemistry
- Investors
- 9 (1 led)
The rounds
- Oct 2025
Everyone who backed them
Mark Goldberg at ChemistryVC firm1round, led 1
employees at AnthropicVC firm1round
employees at DeepMindVC firm1round
employees at OpenAIVC firm1round
employees at VercelVC firm1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 2 firms list Datacurve as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Datacurve
How much has Datacurve raised?
Datacurve has raised $15M across 1 round since 2025.
When did Datacurve last raise?
Datacurve's most recent round was a Series A of $15M in Oct 2025, led by Mark Goldberg at Chemistry.
What was Datacurve's biggest round?
Its most recent round, $15M in Oct 2025, is also its largest on record.
Who backed Datacurve first?
Datacurve's first round on record, in Oct 2025, was backed by Mark Goldberg at Chemistry, Y Combinator and Pioneer Fund and 6 others.
What stage is Datacurve at?
Datacurve's latest named round is a Series A, in Oct 2025.
Who led Datacurve's rounds?
Mark Goldberg at Chemistry led the Series A in 2025.
Companies like Datacurve
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.